Literature DB >> 30999999

Vascular Ehlers-Danlos Syndrome Management: The Paris Way, A Step Forward on a Long Road.

Julie De Backer1, Tine De Backer2.   

Abstract

Keywords:  COL3A1; Ehlers-Danlos syndrome-vascular type; celiprolol; drug therapy; survival

Year:  2019        PMID： 30999999     DOI： 10.1016/j.jacc.2019.02.025

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  4 in total

1.  Targetable cellular signaling events mediate vascular pathology in vascular Ehlers-Danlos syndrome.

Authors:  Caitlin J Bowen; Juan Francisco Calderón Giadrosic; Zachary Burger; Graham Rykiel; Elaine C Davis; Mark R Helmers; Kelly Benke; Elena Gallo MacFarlane; Harry C Dietz
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

2.  Vascular Ehlers-Danlos syndrome: can the beneficial effect of celiprolol be extrapolated to bisoprolol?

Authors:  Maria C Gorosabel; Nicolo Dubacher; Janine Meienberg; Gabor Matyas
Journal:  Eur Heart J Cardiovasc Pharmacother       Date:  2020-07-01

Review 3.  Animal Models of Ehlers-Danlos Syndromes: Phenotype, Pathogenesis, and Translational Potential.

Authors:  Robin Vroman; Anne-Marie Malfait; Rachel E Miller; Fransiska Malfait; Delfien Syx
Journal:  Front Genet       Date:  2021-10-12       Impact factor: 4.599

4.  Comparative therapeutic strategies for preventing aortic rupture in a mouse model of vascular Ehlers-Danlos syndrome.

Authors:  Anne Legrand; Charline Guery; Julie Faugeroux; Erika Fontaine; Carole Beugnon; Amélie Gianfermi; Irmine Loisel-Ferreira; Marie-Christine Verpont; Salma Adham; Tristan Mirault; Juliette Hadchouel; Xavier Jeunemaitre
Journal:  PLoS Genet       Date:  2022-03-04       Impact factor: 6.020
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.